Comfort check: remimazolam vs midazolam for scope sedation
NCT ID NCT07600073
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study observes 126 outpatients getting an endoscopic ultrasound to see which of two common sedatives—remimazolam or midazolam—provides a better experience. Both are already used in routine care, and the choice is up to the doctor. Patients will report their comfort and recovery at 1 and 24 hours after the procedure. The goal is to find which sedation approach leads to less discomfort and faster recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- remimazolam and midazolam (plus fentanyl)
- What this could lead to
- If one sedative proves more tolerable, it could improve patient comfort and recovery for routine endoscopic procedures.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by doctor preference. It is small and single-center, so findings may not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEDATION DURING GI ENDOSCOPY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ospedale Alessandro Manzoni
RECRUITINGLecco, Lecco, 23900, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.